These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23278647)

  • 1. Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.
    Klumpers LE; Roy C; Ferron G; Turpault S; Poitiers F; Pinquier JL; van Hasselt JG; Zuurman L; Erwich FA; van Gerven JM
    Br J Clin Pharmacol; 2013 Jul; 76(1):65-77. PubMed ID: 23278647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
    Klumpers LE; Fridberg M; de Kam ML; Little PB; Jensen NO; Kleinloog HD; Elling CE; van Gerven JM
    Br J Clin Pharmacol; 2013 Dec; 76(6):846-57. PubMed ID: 23601084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.
    Guan Z; Klumpers LE; Oyetayo OO; Heuberger J; van Gerven JM; Stevens J
    Br J Clin Pharmacol; 2016 Apr; 81(4):713-23. PubMed ID: 26617196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist-elicited cannabis withdrawal in humans.
    Gorelick DA; Goodwin RS; Schwilke E; Schwope DM; Darwin WD; Kelly DL; McMahon RP; Liu F; Ortemann-Renon C; Bonnet D; Huestis MA
    J Clin Psychopharmacol; 2011 Oct; 31(5):603-12. PubMed ID: 21869692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.
    Beaumont H; Jensen J; Carlsson A; Ruth M; Lehmann A; Boeckxstaens G
    Br J Pharmacol; 2009 Jan; 156(1):153-62. PubMed ID: 19068079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
    Klumpers LE; Beumer TL; van Hasselt JG; Lipplaa A; Karger LB; Kleinloog HD; Freijer JI; de Kam ML; van Gerven JM
    Br J Clin Pharmacol; 2012 Jul; 74(1):42-53. PubMed ID: 22680341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial.
    Tonstad S; Aubin HJ
    J Psychopharmacol; 2012 Jul; 26(7):1003-9. PubMed ID: 22219220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men.
    Goodwin RS; Baumann MH; Gorelick DA; Schwilke E; Schwope DM; Darwin WD; Kelly DL; Schroeder JR; Ortemann-Renon C; Bonnet D; Huestis MA
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):114-9. PubMed ID: 21797816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
    Bagüés A; Martín MI; Sánchez-Robles EM
    Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.
    Riedel G; Fadda P; McKillop-Smith S; Pertwee RG; Platt B; Robinson L
    Br J Pharmacol; 2009 Apr; 156(7):1154-66. PubMed ID: 19378378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.